Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 507 across all filing types
Latest filing 2021-05-31 Director's Dealing
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when company insiders (directors or major shareholders) trade company stock. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by a company executive (CEO).
2021-05-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including major shareholders and special related parties, and discloses information regarding stock collateral contracts and shareholding purposes. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-05-31 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '올리패스 주식회사' (Olipass Corporation) covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial statements, management analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-17 Korean
기타경영사항(특허권취득)(자율공시)(SCN9A Antisense Pain Killer)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by the company Olipass. It details the patent name, content, and utilization plan. Since it does not fit into specific categories like financial reports, board changes, or dividend announcements, and is a standard regulatory disclosure of corporate activity, it falls under the general regulatory filing category.
2021-05-07 Korean
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) from Olipass Corporation for the fiscal year ending December 31, 2020. It contains comprehensive financial statements, management discussion and analysis, governance information, and auditor opinions. Although it includes a 'Correction Report' (정정신고) header at the beginning, the core content is the full annual financial and operational disclosure, which corresponds to the 10-K filing category in the provided schema. FY 2020
2021-05-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when company insiders (directors, executives, or major shareholders) change their shareholdings. This falls under the category of Director's Dealing (DIRS) as it reports personal share transactions and ownership status of company insiders.
2021-04-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.